Tirzepatide is a dual-receptor medication that activates: GLP-1 receptors GIP receptors This dual action improves appetite suppression, insulin sensitivity, and metabolic efficiency
Symptoms are typically dose-related and occur early in treatment, with many patients seeing improvement within a few weeks as the body adapts to slower gastric emptying and central effects
Leeming, D
After the first use, store at room temperature or in the fridge for up to 56 days
Clinical considerations for specific populations: Individuals with diabetes should consult their GP or diabetes specialist before making significant dietary changes, as alterations in carbohydrate intake and meal timing may affect blood glucose control and medication requirements Those taking insulin or sulfonylureas should be particularly cautious, as dietary changes may increase the risk of hypoglycaemia [15] [16] Those with kidney disease should seek medical advice before substantially increasing protein intake People with digestive disorders (such as irritable bowel syndrome) may need to modify fibre recommendations based on individual tolerance Seek urgent medical attention for severe abdominal pain (especially if radiating to the back), persistent vomiting, blood in stool, or symptoms of hypoglycaemia or hyperglycaemia
Unopened GLP-1 medications stored properly in the refrigerator at 36F to 46F (2C to 8C) remain effective until the expiration date printed on the packaging